News | April 19, 2024
Shilpa Medicare launches Pemetrexed injection
Pemetrexed Injection is used as a drug, in the treatment of non-small cell lung cancer in combination with other chemotherapy agents
Pemetrexed Injection is used as a drug, in the treatment of non-small cell lung cancer in combination with other chemotherapy agents
US FDA and EMA accepted filings based on the data from OCARINA II, with EU approval anticipated mid-2024 and U.S. approval anticipated September 2024
The Product is expected to be the first generic approval on the market
Chlorpromazine Hydrochloride Injection is used to treat certain mental/mood disorders
It is indicated for the inhibition of premature luteinizing hormone (LH) surges in women undergoing controlled ovarian hyperstimulation
The launch will enable PCC to further expand their existing Zinc Sulfate Injection product line and overall the generic injectables portfolio
The product is expected to be launched in December 2023
The transfer of the distribution rights will strengthen Sandoz's immunology and biosimilar portfolio
Methylene blue is a cationic thiazine dye that necessitates specialised capabilities and expertise to develop and manufacture the product
Multi-ethnic innovation helps all complexions appear clearer and more uniform
Subscribe To Our Newsletter & Stay Updated
